Centre tightens checks on GLP-1 weight-loss drug promotion

The Centre has directed states and Union Territories to strengthen monitoring of the supply chain and promotion of GLP-1 weight-loss drugs. Regulators have also been asked to act against surrogate advertisements and misleading campaigns that encourage unsupervised use of prescription medicines